SKIN SkinHealth Systems Inc.
SkinHealth Systems (SKIN) news
SkinHealth Systems Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker SKIN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest SkinHealth Systems news
We have not published a story on SkinHealth Systems yet. When there is news, it will appear here.
SkinHealth Systems annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $300.8 million | $334.3 million |
| Research and development | $5.6 million | $6.3 million |
| Net income (loss) | -$9.5 million | -$29.1 million |
| Cash from operations | $37.5 million | $16.1 million |
| Cash and equivalents | $232.7 million | $370.1 million |
Questions about SkinHealth Systems
What is the ticker symbol of SkinHealth Systems?
SkinHealth Systems Inc. trades under the ticker SKIN on NASDAQ.
Where is SkinHealth Systems listed?
SkinHealth Systems Inc. is listed on NASDAQ.
Which country or territory is SkinHealth Systems listed under?
Our directory records SkinHealth Systems Inc. under United States.
Does aibio.space cover SkinHealth Systems?
aibio.space lists SkinHealth Systems Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was SkinHealth Systems's revenue last year?
$300.8 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is SkinHealth Systems profitable?
SkinHealth Systems Inc. reported a net loss of $9.5 million for the fiscal year ended Dec 31, 2025, and generated $37.5 million of cash from operations, per its annual report to the SEC.
How much does SkinHealth Systems spend on research and development?
$5.6 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does SkinHealth Systems have?
$206.1 million in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: SkinHealth Systems
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,7.01,9.01). Source
- Distress
Reported the end of a material agreement. SEC Form 8-K (Items 1.02,7.01). Source
- Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source
- Legal
Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 8-K (Items 8.01). Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source
Stock chart
Listing details
- Company
- SkinHealth Systems Inc.
- Ticker
- SKIN
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio